181 related articles for article (PubMed ID: 25469512)
1. Recent developments towards podophyllotoxin congeners as potential apoptosis inducers.
Kamal A; Hussaini SM; Malik MS
Anticancer Agents Med Chem; 2015; 15(5):565-74. PubMed ID: 25469512
[TBL] [Abstract][Full Text] [Related]
2. Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin.
Kumar A; Kumar V; Alegria AE; Malhotra SV
Curr Med Chem; 2011; 18(25):3853-70. PubMed ID: 21824101
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic Agents. 585. Isolation of Bridelia ferruginea Anticancer Podophyllotoxins and Synthesis of 4-Aza-podophyllotoxin Structural Modifications.
Pettit GR; Searcy JD; Tan R; Cragg GM; Melody N; Knight JC; Chapuis JC
J Nat Prod; 2016 Mar; 79(3):507-18. PubMed ID: 26938998
[TBL] [Abstract][Full Text] [Related]
5. Podophyllotoxins: current status and recent developments.
Damayanthi Y; Lown JW
Curr Med Chem; 1998 Jun; 5(3):205-52. PubMed ID: 9562603
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010).
Lv M; Xu H
Mini Rev Med Chem; 2011 Sep; 11(10):901-9. PubMed ID: 21781026
[TBL] [Abstract][Full Text] [Related]
7. A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007.
Xu H; Lv M; Tian X
Curr Med Chem; 2009; 16(3):327-49. PubMed ID: 19149581
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents.
Liu J; Cao B; Gao Y; Bai M; Mei X; Chen H; Jiang YG; Huang DJ
J Asian Nat Prod Res; 2013 Sep; 15(9):985-92. PubMed ID: 23859462
[TBL] [Abstract][Full Text] [Related]
9. Discovery of podophyllotoxins.
Imbert TF
Biochimie; 1998 Mar; 80(3):207-22. PubMed ID: 9615861
[TBL] [Abstract][Full Text] [Related]
10. Comparison of carbon-sulfur and carbon-amine bond in therapeutic drug: 4β-S-aromatic heterocyclic podophyllum derivatives display antitumor activity.
Li JL; Zhao W; Zhou C; Zhang YX; Li HM; Tang YL; Liang XH; Chen T; Tang YJ
Sci Rep; 2015 Oct; 5():14814. PubMed ID: 26443888
[TBL] [Abstract][Full Text] [Related]
11. SAR analysis and biological studies of synthesized podophyllum derivates obtained by N linkage modification at C-4 position.
Wang H; Tang L; Tang Y; Yuan Z
Bioorg Med Chem; 2014 Nov; 22(21):6183-92. PubMed ID: 25282651
[TBL] [Abstract][Full Text] [Related]
12. Podophyllotoxin: History, Recent Advances and Future Prospects.
Shah Z; Gohar UF; Jamshed I; Mushtaq A; Mukhtar H; Zia-Ui-Haq M; Toma SI; Manea R; Moga M; Popovici B
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921719
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII.
Yang L; Liu YQ; Tan H; Li WG; Tian X
Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 4β-sulphonamido and 4β-[(4'-sulphonamido)benzamide]podophyllotoxins as DNA topoisomerase-IIα and apoptosis inducing agents.
Kamal A; Suresh P; Ramaiah MJ; Mallareddy A; Imthiajali S; Pushpavalli SN; Lavanya A; Pal-Bhadra M
Bioorg Med Chem; 2012 Mar; 20(6):2054-66. PubMed ID: 22364746
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 4β-N-polyaromatic substituted podophyllotoxins: DNA topoisomerase inhibition, anticancer and apoptosis-inducing activities.
Kamal A; Kumar BA; Suresh P; Agrawal SK; Chashoo G; Singh SK; Saxena AK
Bioorg Med Chem; 2010 Dec; 18(24):8493-500. PubMed ID: 21074444
[TBL] [Abstract][Full Text] [Related]
17. Hemi-synthesis and biological activity of new analogues of podophyllotoxin.
Roulland E; Magiatis P; Arimondo P; Bertounesque E; Monneret C
Bioorg Med Chem; 2002 Nov; 10(11):3463-71. PubMed ID: 12213460
[TBL] [Abstract][Full Text] [Related]
18. Novel 4 beta-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents.
Hu C; Xu D; Du W; Qian S; Wang L; Lou J; He Q; Yang B; Hu Y
Mol Biosyst; 2010 Feb; 6(2):410-20. PubMed ID: 20094661
[TBL] [Abstract][Full Text] [Related]
19. Semi-synthesis and biological evaluation of 1,2,3-triazole-based podophyllotoxin congeners as potent antitumor agents inducing apoptosis in HepG2 cells.
Chen J; Ma L; Zhang R; Tang J; Lai H; Wang J; Wang G; Xu Q; Chen T; Peng F; Qiu J; Liang X; Cao D; Ran Y; Peng A; Wei Y; Chen L
Arch Pharm (Weinheim); 2012 Dec; 345(12):945-56. PubMed ID: 22949330
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in the Chemistry and Biology of Podophyllotoxins.
Yu X; Che Z; Xu H
Chemistry; 2017 Apr; 23(19):4467-4526. PubMed ID: 27726183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
